How has Laboratory Corp. of America Holdings:(NYSE:LH) performed recently?

Laboratory Corp. of America Holdings (NYSE: LH) is a large market cap stock with a market cap of 14192.22. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 22.83, a forward P/E of 14.18 and EPS of 6.05. At a stock price of 137.86 (-0.15%) it has a dividend yield of *TBA.

EPS growth for the last five years have been -3.90%, more recently this last year it has grown by -26.60%. The next year growth is going to be about 10.39% and more long-term 10.08% after five years. EPS growth quarter over quarter is -42.20%. Sales growth for the past five years have been 11.60% and sales growth quarter over quarter is -46.40%.

For performance, Laboratory Corp. of America Holdings the past week has seen a gain of -0.59%. For the last month performance for Laboratory Corp. of America Holdings is 0.17%. While the last quarter is 7.73% and half year, 25.31%. Finally for the year, performance is 19.68%.

The 52-week high for Laboratory Corp. of America Holdings, is at -2.45%, and for the 52-week low it comes to a value of 40.98%. The 20-day simple moving average is 2.01% and 12.18% for the 200-day simple moving average.

Volatility for the week is at 0.87%, and for the month it is 1.13%. Laboratory Corp. of America Holdings, has a target price of 150.1.

In terms of debt, long term debt/equity is 1.12, and for total debt/equity Laboratory Corp. of America Holdings has 1.14. The gross margin is 33.00%, while operating margin is 12.90%, the profit margin is 6.60%. The current ratio is 2.1 and the quick ratio is 1.9.

Insider ownership is at 0.30%, with instituitional ownership at 94.80%. Laboratory Corp. of America Holdings has a payout ratio of 0.00%. With the total shares outstanding coming to 102.79. The shares float is 101.94, with the float short at 3.02%, with short ratio coming to 3.68.

In terms of returns, the return on assets see Laboratory Corp. of America Holdings, get 4.40%, with its returns on investment at 6.30%. Return on equity is 12.40%. So will the investors see the target price of 150.1, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.